ArticlePublic health reviews2022
Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.
Article in Public health reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- From fragmentation to integration: Patient-reported access to cardiovascular care in Colombia's primary health system.Revista panamericana de salud publica = Pan American journal of public health · 2026Article
- A Review on the Double Burden of Diabetes and Myocardial Infarction: Healthcare Challenges and Future Prospects in Low and Middle-Income Countries.Health science reports · 2025Article
- Socioeconomic determinants of affordability of medication: a panel data econometric analysis in Iran.BMC health services research · 2025Article
- Perceived barriers to management of patients with diabetes mellitus and hypertension in primary care centers in Indonesia.Frontiers in health services · 2025Article
- Pakistan's first medicine price deregulation policy: assessing its impact on prices, affordability, and availability of oral anti-diabetic medicines in private pharmacies.Frontiers in pharmacology · 2025Article
- Access to medicines for the treatment of chronic diseases in Chile: qualitative analysis of perceived patient barriers and facilitators in five regions of the country.BMC health services research · 2024Article
- Decentralization Matters: Association of Adherence to Treatment and Distance for the Management of Non-Communicable Diseases in Rural Tanzania.International journal of environmental research and public health · 2024Article
- Delivering non-communicable disease services through primary health care in selected south Asian countries: are health systems prepared?The Lancet. Global health · 2024Review
- Barriers to adherence to secondary prevention therapy in patients with ischemic heart disease: a cross-sectional study of a Mexican reference center.Archivos de cardiologia de Mexico · 2024Article
- Lived experiences of people living with HIV and hypertension or diabetes access to care in Ethiopia: a phenomenological study.BMJ open · 2024Article
- Article
- Article
- Type 2 Diabetes Prevention Programs-From Proof-of-Concept Trials to National Intervention and Beyond.Journal of clinical medicine · 2023Review
- Contribution analysis of drug coverage policies on access to medicines for diabetes, dyslipidemia and hypertension in Chile.The journal of medicine accessArticle
- Association Between Alcohol Consumption and Blood Pressure Levels Among HIV Sero-Positive and Sero-Negative Cohorts: A Secondary Analysis of the Vukuzazzi Study.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.